Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Science Advances
|
May 23, 2024
A synthetic lethal dependency on casein kinase 2 in response to replication-perturbing therapeutics in RB1-deficient cancer cells
Daria Bulanova, Yevhen Akimov, Wojciech Senkowski, et al.
Immunopharmacology and Immunotoxicology
|
May 6, 2017
The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation
Kristin Blom, Wojciech Senkowski, Malin Jarvius, et al.
Experimental Cell Research
|
November 7, 2017
Targeting tumor cells based on Phosphodiesterase 3A expression
Madiha Nazir, Wojciech Senkowski, Frida Nyberg, et al.
Scientific Reports
|
December 8, 2016
Iron chelators target both proliferating and quiescent cancer cells
Mårten Fryknäs, Xiaonan Zhang, Ulf Bremberg, et al.
Cancer Discovery
|
July 30, 2025
Decoding the Genomic and Functional Landscape of Emerging Subtypes in Ovarian Cancer
Giulia Micoli, Kari Lavikka, Yilin Li, et al.
Molecular Cancer Therapeutics
|
January 28, 2025
Identification of a TNIK-CDK9 Axis as a Targetable Strategy for Platinum-Resistant Ovarian Cancer
Noah Puleo, Harini Ram, Michele L Dziubinski, et al.
Nature Communications
|
October 3, 2024
Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones
Aleksandr Ianevski, Kristen Nader, Kyriaki Driva, et al.
Cancer Cell
|
May 19, 2023
Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma
Alexandra Lahtinen, Kari Lavikka, Anni Virtanen, et al.
Genome Medicine
|
July 4, 2026
Multi-modal data integration reveals functionally credible predictive biomarkers in ovarian cancer
Taru A Muranen, Andreas Hainari, Daria Afenteva, et al.
Developmental Cell
|
May 6, 2023
A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids
Wojciech Senkowski, Laura Gall-Mas, Matías Marín Falco, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Science Advances
|
May 23, 2024
A synthetic lethal dependency on casein kinase 2 in response to replication-perturbing therapeutics in RB1-deficient cancer cells
Daria Bulanova, Yevhen Akimov, Wojciech Senkowski, et al.
Immunopharmacology and Immunotoxicology
|
May 6, 2017
The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation
Kristin Blom, Wojciech Senkowski, Malin Jarvius, et al.
Experimental Cell Research
|
November 7, 2017
Targeting tumor cells based on Phosphodiesterase 3A expression
Madiha Nazir, Wojciech Senkowski, Frida Nyberg, et al.
Scientific Reports
|
December 8, 2016
Iron chelators target both proliferating and quiescent cancer cells
Mårten Fryknäs, Xiaonan Zhang, Ulf Bremberg, et al.
Cancer Discovery
|
July 30, 2025
Decoding the Genomic and Functional Landscape of Emerging Subtypes in Ovarian Cancer
Giulia Micoli, Kari Lavikka, Yilin Li, et al.
Molecular Cancer Therapeutics
|
January 28, 2025
Identification of a TNIK-CDK9 Axis as a Targetable Strategy for Platinum-Resistant Ovarian Cancer
Noah Puleo, Harini Ram, Michele L Dziubinski, et al.
Nature Communications
|
October 3, 2024
Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones
Aleksandr Ianevski, Kristen Nader, Kyriaki Driva, et al.
Cancer Cell
|
May 19, 2023
Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma
Alexandra Lahtinen, Kari Lavikka, Anni Virtanen, et al.
Genome Medicine
|
July 4, 2026
Multi-modal data integration reveals functionally credible predictive biomarkers in ovarian cancer
Taru A Muranen, Andreas Hainari, Daria Afenteva, et al.
Developmental Cell
|
May 6, 2023
A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids
Wojciech Senkowski, Laura Gall-Mas, Matías Marín Falco, et al.
Page
of 2